Andrew Boyle is currently Professor of Cardiovascular Medicine, Clinical Dean of the Hunter Clinical School of the University of Newcastle and a practising interventional cardiologist. He has over 100 career journal publications, eight book chapters and three patents. Andrew heads both a clinical and a basic science research team.
He started studying left ventricular remodelling as the subject of his PhD (2002-5) and has continued in this field ever since. He has considerable experience in rodent models, porcine models and human clinical trials.
While his laboratory continues to study in vitro and preclinical models of cardiac fibrosis, LV remodeling and cardiac regeneration, he is also international PI on a clinical trial of a novel drug for post-infarction LV remodeling, conducted at over 15 sites world-wide. His clinical research focuses on acute coronary syndromes, including novel risk stratification parameters and optimising treatment strategies especially in rural and remote locations.